Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tuberous sclerosis complex: genetics to pathogenesis.

Vinodh Narayanan1

  • 1Barrow Neurological Institute, St. Joseph's Hospital and Medical Center, Phoenix, Arizona 85013, USA.

Pediatric Neurology
|December 20, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

ISGylation is disrupted by <i>UBA7</i> gene variants identified in individuals with neurodevelopmental disorder phenotypes.

iScience·2026
Same author

Integration of Genome and Epigenetic Testing in the Diagnostic Evaluation of Developmental Delay: Differentiating Börjeson-Forssman-Lehmann (BFLS) and White-Kernohan (WHIKERS) Syndromes.

Genes·2025
Same author

Pathogenic de novo variants in PPP2R5C cause a neurodevelopmental disorder within the Houge-Janssens syndrome spectrum.

American journal of human genetics·2025
Same author

De novo variants in RYBP are associated with a severe neurodevelopmental disorder and congenital anomalies.

Genetics in medicine : official journal of the American College of Medical Genetics·2025
Same author

Duchenne Muscular Dystrophy in Two Half-Brothers Due to Inherited 306 Kb Inverted Insertion of 10p15.1 into Intron 44 of the Dp427m Transcript of the <i>DMD</i> Gene.

International journal of molecular sciences·2024
Same author

Recurrent p.H119Y variant in MAP2K1 expands the phenotypic spectrum of MAP2K1 -related RASopathy.

American journal of medical genetics. Part A·2024

Tuberous sclerosis complex (TSC) is a genetic disorder causing tumors in multiple organs. This review explores the function of TSC1 (hamartin) and TSC2 (tuberin) genes and their role in TSC pathogenesis.

Area of Science:

  • Genetics
  • Cellular Biology
  • Neurology

Background:

  • Tuberous sclerosis complex (TSC) is a genetic disorder characterized by hamartomas in various organs, notably the brain.
  • Clinical manifestations include skin lesions, developmental delays, seizures, and involvement of kidneys, heart, and retina.
  • The majority of TSC cases (65%) are sporadic, but familial cases led to gene identification.

Purpose of the Study:

  • To review current understanding of tuberin and hamartin functions.
  • To elucidate the pathogenesis of tuberous sclerosis complex.
  • To explore the molecular mechanisms underlying TSC.

Main Methods:

  • Literature review of genetic linkage studies.
  • Analysis of protein homology and interactions.

Related Experiment Videos

  • Review of cellular and molecular pathways involved in TSC.

    • Main Results:

    • TSC is linked to mutations in two genes: TSC1 (chromosome 9q34, encoding hamartin) and TSC2 (chromosome 16p13.3, encoding tuberin).
    • Tuberin shows homology to a GTPase-activating protein, suggesting a role in cellular signaling.
    • Hamartin interacts with cytoskeletal proteins, and tuberin and hamartin directly interact, forming a complex.
    • The tuberin-hamartin complex is implicated in regulating cellular processes relevant to TSC pathogenesis.

    Conclusions:

    • The tuberin-hamartin complex plays a critical role in the pathogenesis of tuberous sclerosis complex.
    • Understanding the function of these proteins and their interactions is key to deciphering TSC.
    • Further research into these pathways may reveal therapeutic targets for TSC.